Corient Private Wealth’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Sell
9,234
-2,312
-20% -$90.3K ﹤0.01% 2245
2026
Q1
$408K Sell
11,546
-10,386
-47% -$322K ﹤0.01% 2137
2025
Q4
$612K Sell
21,932
-19,431
-47% -$582K ﹤0.01% 1763
2025
Q3
$1.24M Sell
41,363
-129
-0.3% -$3.64K ﹤0.01% 1319
2025
Q2
$1.19M Buy
41,492
+1,517
+4% +$45.1K ﹤0.01% 1281
2025
Q1
$1.32M Sell
39,975
-469
-1% -$15.3K ﹤0.01% 1160
2024
Q4
$1.16M Sell
40,444
-36
-0.1% -$1.03K ﹤0.01% 1254
2024
Q3
$1.13M Buy
40,480
+45
+0.1% +$1.2K ﹤0.01% 1347
2024
Q2
$974K Buy
40,435
+17,669
+78% +$433K ﹤0.01% 1343
2024
Q1
$616K Buy
22,766
+13,420
+144% +$381K ﹤0.01% 1520
2023
Q4
$259K Buy
+9,346
New +$243K ﹤0.01% 1941

Other funds holding ALKS

Corient Private Wealth's ALKS Position: Q2 2026 in Review

Corient Private Wealth reduced its Alkermes (ALKS) stake by 20% in Q2 2026, selling an estimated $90.3K and leaving 9,234 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Corient Private Wealth first reported a position in ALKS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.32M in Q1 2025. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Corient Private Wealth held 9,234 shares of Alkermes worth $484K as of Q2 2026.
  • Corient Private Wealth sold 2,312 Alkermes shares in Q2 2026, an estimated $90.3K.
  • Alkermes made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2245 holding.
  • Corient Private Wealth first reported a position in Alkermes in Q4 2023 and has held it in 11 quarters since.
  • Corient Private Wealth's Alkermes position peaked at $1.32M in Q1 2025.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.